Paper34366147
Cellular senescence at the crossroads of inflammation and Alzheimer's disease.
Guerrero A and 2 others. Trends Neurosci, 2021. Cited by 200 papers, by iCite.
Cite this record
ConductScience Library. Cellular senescence at the crossroads of inflammation and Alzheimer's disease. Papers, record 34366147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34366147
- Disease
- Alzheimer disease441 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Aged | |
| Aging | |
| Cellular Senescence | |
| Humans | |
| Inflammation | |
| Phenotype |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Medical Research Council | United Kingdom | PubMed |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04685590 | Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT04785300 | ALSENLITE: Senolytics for Alzheimer's Disease | Derived from the trial | Yes | ClinicalTrials.gov |
Cited by138
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 200 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939272 | Brain Aging and Cellular Senescence Trigger Neuroimmunological Dysregulation and Neurodegeneration. | Brain Sci | 2026 | https://conductscience.org/library/papers/42939272 | PubMed |
| 42861725 | Paracrine bone-derived senescent secretome is associated with spatially patterned extracellular matrix remodeling and altered biomechanics in human brain organoids. | Stem Cells | 2026 | https://conductscience.org/library/papers/42861725 | PubMed |
| 42680931 | Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy. | Biogerontology | 2026 | https://conductscience.org/library/papers/42680931 | PubMed |
| 42654174 | Food-Derived Omega-3 Fatty Acids and Cognitive Aging: Integrating Nutritional Neuroscience and Geroscience. | Nutrients | 2026 | https://conductscience.org/library/papers/42654174 | PubMed |
| 42552384 | A reproducible three-dimensional model of human brain tissue to investigate physiological and disease-associated microglia phenotypes. | Nat Neurosci | 2026 | https://conductscience.org/library/papers/42552384 | PubMed |
| 42446473 | Multilayer Proteome and Metabolome-Based Validation Uncovers Combined Regulatory Roles and Predictive Values of 6 RNA Modifications and Cellular Senescence in Alzheimer's Disease. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42446473 | PubMed |
| 42420256 | Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease? | Transl Psychiatry | 2026 | https://conductscience.org/library/papers/42420256 | PubMed |
| 42412302 | Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ1-42-Induced Alzheimer's Disease Model Mice. | J Neuroimmune Pharmacol | 2026 | https://conductscience.org/library/papers/42412302 | PubMed |
| 42324173 | Senescent Human Liver Endothelial Cells Mediate CD4+ T Cell Recruitment via ICOSL. | Immunology | 2026 | https://conductscience.org/library/papers/42324173 | PubMed |
| 42268464 | Advances in anti-tau therapeutics for alzheimer's disease: immunotherapy, gene modulation, and combination approaches. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42268464 | PubMed |
| 42081929 | uPAR exhibits age- and region-dependent expression in the brains of mice with Alzheimer's disease-like pathology. | Brain Res | 2026 | https://conductscience.org/library/papers/42081929 | PubMed |
| 42072300 | Cellular Senescence in Neurodegeneration: From Cell Types to Therapeutic Opportunities. | Biomedicines | 2026 | https://conductscience.org/library/papers/42072300 | PubMed |
| 42057007 | PTP1B in astrocytes drives pathogen-induced neurodegeneration. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42057007 | PubMed |
| 41870677 | Senescence as a Central Node in Alzheimer's Disease: Molecular Triggers, Cellular Effectors, and RNA-Based Interventions. | Neurochem Res | 2026 | https://conductscience.org/library/papers/41870677 | PubMed |
| 41851074 | Identification of plasma biomarkers in lipid metabolism for accurate prediction of Alzheimer's disease. | Transl Psychiatry | 2026 | https://conductscience.org/library/papers/41851074 | PubMed |
| 41526954 | Promoting the nuclear retention of HMGB1 attenuates astrocyte senescence. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/41526954 | PubMed |
| 41489638 | Cell senescence-related pathogenic genes in sleep disorders: a multi-omics Mendelian randomization study. | Eur Arch Psychiatry Clin Neurosci | 2026 | https://conductscience.org/library/papers/41489638 | PubMed |
| 41445867 | Mapping microglial mechanisms in Alzheimer's disease: a comprehensive analysis. | Exp Biol Med (Maywood) | 2025 | https://conductscience.org/library/papers/41445867 | PubMed |
| 41441223 | Senotherapeutics for Brain Aging Management. | Neurol Int | 2025 | https://conductscience.org/library/papers/41441223 | PubMed |
| 41272336 | Dual Mechanisms of Cognitive Function and Pathological Improvements by the Selective S1PR1/5 Modulator Siponimod in 3xTg-AD Mice. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41272336 | PubMed |
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| DASATINIB ANHYDROUS | CHEMBL1421 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1421 | ChEMBL |
| QUERCETIN | CHEMBL50 | Derived from the trial | 2 | https://conductscience.org/library/drugs/CHEMBL50 | ChEMBL |
| DASATINIB | CHEMBL5416410 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL5416410 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34366147
GET https://conductscience.org/api/papers/v1/34366147/cited_by?page=2